EMEA-001644-PIP02-14

Key facts

Invented name
Truvada
Active substance
  • emtricitabine
  • tenofovir disoproxil fumarate
Therapeutic area
Infectious diseases
Decision number
P/0256/2015
PIP number
EMEA-001644-PIP02-14
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
  • Prevention of human immunodeficiency virus (HIV-1) infection
  • Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
Gilead Sciences International Ltd
United Kingdom
Tel. +44 1223 897342
E-mail: regulatory.pip@gilead.com
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating